spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

7th American Drug Delivery & Formulation Summit

7th American Drug Delivery & Formulation Summit

28-29 August 2017
The Westin Copley Place Boston Hotel

7th American Drug Delivery & Formulation Summit
28 – 29 August 2017 | Boston

Innovative solutions to the greatest challenges in pharmaceutical development

The growth of biopharma and patient compliance issues have encouraged us to adopt a drug delivery mind set from discovery through to production.

Every year we see innovation and breakthroughs at every level of drug development.

The DDF Summit brings the most innovative and exciting studies to you.

Covering both small molecules and biologics, you’ll find new technologies, concepts and case studies in areas such as…

• Formulation design for poorly soluble compounds
• The potential of nanotechnology for better deliverability
• The latest controlled released technologies
• Improving patient compliance by harnessing data and the latest smart device technology
• Optimising formulations for continuous manufacturing
• Overcoming the blood brain barrier and challenges in oral delivery of biologics
• Reformulation and biosimilars
phone +44 (0)20 8269 7110
email mabconferences@markallengroup.com
web www.ddfsummit.com
email The Westin Copley Place Boston Hotel, 10 Huntingdon Ave, Boston, MA 02116
 
Print this page
Send to a friend
   
spacer
Industry Events

Outsourcing in Clinical Trials Medical Devices 2017

27-28 June 2017, Santa Clara, CA

OCT Medical Devices moved to Irvine, California for the first year in 2016, and we are pleased to say it proved a resounding success. As the only event to cater for the Southern California Medical device hub in Irvine, it brought together a variety of medical device companies of all sizes, including Medtronic, Edwards Lifesciences, Onciomed, Inc and St Jude Medical.
More info >>

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>


News and Press Releases

New research calls for pathology services to be better funded and prioritised


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement